(NASDAQ: SHC) Sotera Health Co's forecast annual revenue growth rate of 6.52% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.32%.
Sotera Health Co's revenue in 2026 is $1,163,617,000.On average, 12 Wall Street analysts forecast SHC's revenue for 2026 to be $355,774,490,829, with the lowest SHC revenue forecast at $342,976,847,274, and the highest SHC revenue forecast at $371,131,663,095. On average, 12 Wall Street analysts forecast SHC's revenue for 2027 to be $377,103,896,754, with the lowest SHC revenue forecast at $362,599,900,725, and the highest SHC revenue forecast at $395,304,989,810.
In 2028, SHC is forecast to generate $400,424,047,232 in revenue, with the lowest revenue forecast at $384,782,482,887 and the highest revenue forecast at $419,762,708,604.